Here’s Why Gilead Sciences, Inc (GILD) Stock May Continue To Slide

Gilead recorded its largest ever one-day decline yesterday after Express Scripts dropped the company’s hepatitis C drugs for a competitor’s treatment. Gilead may be in for some more bad news soon if Achillion releases positive trial results for its experimental hepatitis C combo, ACH-3102

GILD ACHN ABBV ESRX http://www.bidnessetc.com/31504-gilead-sciences-gild-may-have-to-cut-price-of-hepatitis-c-drug-to-battle-co/

By: HANNAH ISHMAEL
Published: Dec 23, 2014 at 5:46 am EST 
Read more ....